Rich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML Patients – GlobeNewswire (press release)
|
Rich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML Patients
GlobeNewswire (press release) BEVERLY HILLS, CA , April 10, 2018 (GLOBE NEWSWIRE) — Rich Pharmaceuticals, Inc. (OTC: RCHA), a Biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology, discusses how its Targeted Immunotherapy works in … |
